Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIENCY) EQUITY

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIENCY) EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2020 $ 10 $ 915,755 $ (909,441) $ (1,875) $ 4,449
Balance (in shares) at Mar. 31, 2020 10,286,366        
Balance, treasury stock (in shares) at Mar. 31, 2020       57,577  
Increase (Decrease) in Stockholders' Equity          
Net loss         (1,139)
Balance at Jun. 30, 2020         4,991
Balance at Mar. 31, 2020 $ 10 915,755 (909,441) $ (1,875) 4,449
Balance (in shares) at Mar. 31, 2020 10,286,366        
Balance, treasury stock (in shares) at Mar. 31, 2020       57,577  
Increase (Decrease) in Stockholders' Equity          
Net loss         (6,812)
Balance at Sep. 30, 2020         (501)
Balance at Mar. 31, 2020 $ 10 915,755 (909,441) $ (1,875) 4,449
Balance (in shares) at Mar. 31, 2020 10,286,366        
Balance, treasury stock (in shares) at Mar. 31, 2020       57,577  
Increase (Decrease) in Stockholders' Equity          
Net loss         (15,662)
Balance at Dec. 31, 2020         (8,342)
Balance at Mar. 31, 2020 $ 10 915,755 (909,441) $ (1,875) 4,449
Balance (in shares) at Mar. 31, 2020 10,286,366        
Balance, treasury stock (in shares) at Mar. 31, 2020       57,577  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (74) (74)
Purchase of treasury stock (in shares)       16,377  
Vested restricted stock awards   74     74
Vested restricted stock awards (in shares) 71,767        
Stock-based compensation   937     937
Issuance of common stock, net of issuance costs $ 3 16,778     16,781
Issuance of common stock, net of issuance costs (in shares) 2,130,634        
Stock awards to Board of Directors   (38)     (38)
Stock awards to Board of Directors (in shares) 57,098        
Warrants issued   761     761
Warrants exercised (in shares) 352,279        
Change in warrants valuation   99     99
Deemed dividend on purchase warrant for common shares   15 (15)    
Net loss     (20,757)   (20,757)
Balance at Mar. 31, 2021 $ 13 934,381 (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144       12,898,144
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954 73,954
Balance at Jun. 30, 2020         $ 4,991
Increase (Decrease) in Stockholders' Equity          
Net loss         (5,673)
Balance at Sep. 30, 2020         (501)
Increase (Decrease) in Stockholders' Equity          
Net loss         (8,850)
Balance at Dec. 31, 2020         (8,342)
Increase (Decrease) in Stockholders' Equity          
Net loss         (5,095)
Balance at Mar. 31, 2021 $ 13 934,381 (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144       12,898,144
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954 73,954
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (4,221)
Balance at Jun. 30, 2021         9,521
Balance at Mar. 31, 2021 $ 13 934,381 (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144       12,898,144
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954 73,954
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (9,783)
Balance at Sep. 30, 2021         4,227
Balance at Mar. 31, 2021 $ 13 934,381 (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144       12,898,144
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954 73,954
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (15,071)
Balance at Dec. 31, 2021         (726)
Balance at Mar. 31, 2021 $ 13 934,381 (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144       12,898,144
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954 73,954
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (139) $ (139)
Purchase of treasury stock (in shares)       27,679  
Vested restricted stock awards   100     100
Vested restricted stock awards (in shares) 124,184        
Stock-based compensation   1,245     1,245
Issuance of common stock, net of issuance costs $ 2 11,243     11,245
Issuance of common stock, net of issuance costs (in shares) 2,305,780        
Stock awards to Board of Directors (in shares) 70,260        
Net loss     (22,370)   (22,370)
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633
Balance at Jun. 30, 2021         $ 9,521
Increase (Decrease) in Stockholders' Equity          
Net loss         (5,562)
Balance at Sep. 30, 2021         4,227
Increase (Decrease) in Stockholders' Equity          
Net loss         (5,288)
Balance at Dec. 31, 2021         (726)
Increase (Decrease) in Stockholders' Equity          
Net loss         (7,299)
Balance at Mar. 31, 2022 $ 15 $ 946,969 $ (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633